Carbon Nanotube Composite Vector for Synergistic Photothermal and Gene Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current photothermal therapy and gene therapy methods for tumor treatment face challenges such as damage to normal tissue, inflammation, and low efficiency of photothermal material concentration and gene transfer, particularly with carbon nanotubes experiencing agglomeration and poor biocompatibility and gene carrying capabilities.
Innovation Solution
A carbon nanotube composite vector is developed by non-covalent modification with a peptide lipid, loaded with genes, and combined with additives like digoxin, celecoxib, and resveratrol, to enhance biocompatibility and photothermal conversion efficiency, allowing for targeted delivery and synergistic photothermal and gene therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Use of energy by moving object
If carbon nanotubes are used as photothermal material, then photothermal conversion efficiency is improved, but in vivo agglomeration and accumulation occur
Solution Approach 1:
The patent combines carbon nanotubes with peptide lipids to form a composite vector system. The peptide lipid component (with hydrophilic head and hydrophobic tail) modifies the surface of carbon nanotubes, improving water solubility and biocompatibility while preventing agglomeration. This composite structure maintains the photothermal conversion efficiency of carbon nanotubes while adding the biocompatibility benefits of peptide lipids.
Solution Approach 2:
The patent modifies the surface properties of carbon nanotubes through non-covalent modification with peptide lipids. This changes physical parameters such as surface charge, hydrophilicity, and colloidal stability, thereby improving biocompatibility and preventing in vivo agglomeration while preserving the core photothermal functionality.
2Ease of operation
If carbon nanotubes are used for drug delivery, then cell membrane penetration is improved, but gene transfer efficiency is reduced
Solution Approach 1:
The patent creates a composite vector combining carbon nanotubes (which provide cell membrane penetration capability) with peptide lipids (which provide gene complexing and transfer efficiency). The peptide lipid forms a bridge between the carbon nanotube and the gene, enabling both efficient cell entry and effective gene delivery.
Solution Approach 2:
The peptide lipid acts as an intermediary component that mediates between the carbon nanotube and the gene. It binds to the gene through electrostatic interactions and simultaneously attaches to the carbon nanotube surface, facilitating both protection of the gene and efficient cellular uptake while maintaining high transfer efficiency.
3Productivity
If photothermal therapy is applied, then tumor cell killing is improved, but damage to normal tissue and inflammation occur
Solution Approach 1:
The patent employs targeted delivery where the carbon nanotube-peptide lipid composite vector accumulates specifically at the tumor site through passive targeting (EPR effect) and active targeting mechanisms. The photothermal treatment is then locally applied only at the tumor location, ensuring that normal surrounding tissues are not exposed to excessive heat and inflammation is minimized.
Solution Approach 2:
The patent utilizes the inherent ability of carbon nanotubes to convert light energy to heat (which could potentially cause damage) and transforms this into a beneficial localized thermal effect. By controlling the photothermal conversion to occur only at the tumor site through targeted accumulation, the heat effect becomes therapeutic rather than harmful to normal tissues.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composite vector improves gene transfer efficiency, reduces cytotoxicity, and achieves higher photothermal conversion performance, effectively killing tumor cells while minimizing damage to surrounding tissues, offering a more effective combined therapy approach.
Implementation Method 1
a material having high photothermal conversion efficiency is injected into a human body and then gathers near the tumor tissue by using targeted recognition technology, and light energy is converted into heat energy under the irradiation of external near-infrared light
Implementation Method 2
the structure in which the head is hydrophilic and the tail is hydrophobic has been used to prepare cationic liposomes by self-assembly, drugs and genes can be effectively transferred
Implementation Method 3
The carbon nanotube is a tubular carbon molecule, having the diameter ranging from one nanometer to tens of nanometers, and the length ranging from a few nanometers to half a meter. The SP2 hybridization of carbon atoms of the carbon nanotube and the arrangement of carbon-carbon σ bonds make the carbon nanotube widely applied in medicine, because it can adsorb a variety of drugs and easily penetrate cell membranes
Data Source
AI summary
A carbon nanotube composite vector having a synergistic effect of photothermal therapy and gene therapy, a preparation method therefor, and an application thereof. The vector includes a vector moiety and a gene, and the vector moiety includes carbon nanotubes, a peptide lipid, and/or an additive. A modifier is immobilized on the carbon nanotubes by a self-assembly process to prepare the composite vector that can carry and transfer the gene. The composite vector overcomes the problems that pure carbon nanotubes have poor water solubility, low biocompatibility, and poor gene carrying and transfer efficiency; moreover, the composite vector has higher photothermal conversion performances and gene transfer efficiency, reduces cytotoxicity of carbon nanotubes, and alleviates the problem of localized accumulation of carbon nanotubes. The synergistic effect of photothermal therapy and gene therapy is applied to resolve the problem in tumor treatment that the efficacy of a single treatment method is poor.